Stalica raises $17.5m to advance neurology programmes
The Switzerland based company plans to use the Series B money to fund clinical trials for its three pipeline candidates.
The Switzerland based company plans to use the Series B money to fund clinical trials for its three pipeline candidates.
What's Your Reaction?
